Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 25, 2000, Pages 13778-13783

  Lempicki, Richard A ^a   Kovacs, Joseph A ^d   Baseler, Michael W ^a   Adelsberger, Joseph W ^a   Dewar, Robin L ^a   Natarajan, Ven ^a   Bosche, Marjorie C ^a   Metcalf, Julia A ^e   Stevens, Randy A ^a   Lambert, Laurie A ^a   Alvord, W Gregory ^b   Polis, Michael A ^e   Davey, Richard T ^e   Dimitrov, Dimiter S ^c   Lane, H Clifford ^e  

^a SAIC FREDERICK INC   (United States)

^b Data Management Services Inc   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Clinical Center

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

AIDS; Immune activation; Proliferation; T cell receptor rearrangement excision circles

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ANTIGENS, CD45; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, ANTIGEN, T-CELL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 12944331410     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.250472097     Document Type: Article

References (24)

1. Lane, H. C., Depper, J. M., Greene, W. C., Whalen, G., Waldmann, T. A. & Fauci, A. S. (1985) N. Engl. J. Med. 313, 79-84.
2. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) Nature (London) 373, 117-122.
3. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. (1995) Nature (London) 373, 123-126.
4. Stein, D. S. & Drusano, G. L. (1997) Antimicrob. Agents Chemother. 41, 449-453.
5. Mosier, D. E. (1995) Nature (London) 375, 193-194.
6. Sprent, J. & Tough, D. (1995) Nature (London) 375, 194.
7. Dimitrov, D. S. & Martin, M. A. (1995) Nature (London) 375, 194-195.
8. Pakker, N. G., Notermans, D. W., de Boer, R. J., Roos, M. T., de Wolf, F., Hill, A., Leonard, J. M., Danner, S. A., Miedema, F. & Schellekens, P. T. (1998) Nat. Med. 4, 208-214
9. Mohri, H., Bonhoeffer, S., Monard, S., Perelson, A. S. & Ho, D. D. (1998) Science 279, 1223-1227.
10. Zhang, Z. Q., Notermans, D. W., Sedgewick, G., Cavert, W., Wietgrefe, S., Zupancic, M., Gebhard, K., Henry, K., Boies, L., Chen, Z., et al. (1998) Proc. Natl. Acad. Sci. USA 95, 1154-1159.
11. Tenner-Racz, K., Stellbrink, H. J., van Lunzen, J., Schneider, C., Jacobs, J. P., Raschdorff, B., Grosschupff, G., Steinman, R. M. & Racz, P. (1998) J. Exp. Med. 187, 949-959.
12. Sachsenberg, N., Perelson, A. S., Yerly, S., Schockmel, G. A., Leduc, D., Hirschel, B. & Perrin, L. (1998) J. Exp. Med. 187, 1295-1303.
13. Rosenzweig, M., DeMaria, M., Harper, D. M., Friedrich, S., Jain, R. K. & Johnson, R. P. (1998) Proc. Natl. Acad. Sci. USA 95, 6388-6393.
14. Fleury, S., de Boer, R. J., Rizzardi, G. P., Wolthers, K. C., Otto, S. A., Welbon, C. C., Graziosi, C., Knabenhans, C., Soudeyns, H., Bart, P. A., et al. (1998) Nat. Med. 4, 794-801.
15. Hellerstein, M., Hanley, M. B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., Schmidt, D., Hoh, R., Neese, R., Macallan, D., et al. (1999) Nat. Med. 5, 83-89.
16. Davey, R. T., Jr., Bhat, N., Yoder, C., Chun, T. W., Metcalf, J. A., Dewar, R., Natarajan, V., Lempicki, R. A., Adelsberger, J. W., Miller, K. D., et al. (1999) Proc. Natl. Acad. Sci. USA 96, 15109-15114.
17. Hazenberg, M. D., Stuart, J. W., Otto, S. A., Borleffs, J. C., Boucher, C. A., de Boer, R. J., Miedema, F. & Hamann, D. (2000) Blood 95, 249-255.
18. Fleury, S., Rizzardi, G. P., Chapuis, A., Tambussi, G., Knabenhans, C., Smieoni, E., Meuwly, J. Y., Corpataux, J. M., Lazzarin, A., Miedema, F. & Pantaleo, G. (2000) Proc. Natl. Acad. Sci. USA 97, 5393-5398.
19. McCune, J. M., Hanley, M. B., Cesar, D., Halvorsen, R., Hoh, R., Schmidt, D., Wieder, E., Decks, S., Siler, S., Neese, R. & Hellerstein, M. (2000) J. Clin. Invest. 105, R1-R8.
20. Tough, D. F. & Sprent, J. (1994) J. Exp. Med. 179, 1127-1135.
21. National Cancer Institute (1996) Annual Report to the Food and Drug Administration: Bromodeoxyuridine (National Cancer Institute, Bethesda, MD).
22. Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan, J. L., et al. (1998) Nature (London) 396, 690-695.
23. Highbarger, H. C., Alvord, W. G., Jiang, M. K., Shah, A. S., Metcalf, J. A., Lane, H. C. & Dewar, R. L. (1999) J. Clin. Microbiol. 37, 3612-3614.
24. Zhang, L., Lewin, S. R., Markowitz, M., Lin, H. H., Skulsky, E., Karanicolas, R., He, Y., Jin, X., Tuttleton, S., Vesanen, M., et al. (1999) J. Exp. Med. 190, 725-732.